Whole genomic sequencing based genotyping reveals a specific X3 sublineage restricted to Mexico and related with multidrug resistance.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 01 2021
Historique:
received: 21 07 2020
accepted: 08 12 2020
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 21 9 2021
Statut: epublish

Résumé

Whole genome sequencing (WGS) has been shown to be superior to traditional procedures of genotyping in tuberculosis (TB), nevertheless, reports of its use in drug resistant TB (DR-TB) isolates circulating in Mexico, are practically unknown. Considering the above the main of this work was to identify and characterize the lineages and genomic transmission clusters present in 67 DR-TB isolates circulating in southeastern Mexico. The results show the presence of three major lineages: L1 (3%), L2 (3%) and L4 (94%), the last one included 16 sublineages. Sublineage 4.1.1.3 (X3) was predominant in 18 (27%) of the isolates, including one genomic cluster, formed by eleven multidrug resistant isolates and sharing the SIT 3278, which seems to be restricted to Mexico. By the use of WGS, it was possible to identify the high prevalence of L4 and a high number of sublineages circulating in the region, also was recognized the presence of a novel X3 sublineage, formed exclusively by multidrug resistant isolates and with restrictive circulation in Mexico for at least the past 17 years.

Identifiants

pubmed: 33479318
doi: 10.1038/s41598-020-80919-5
pii: 10.1038/s41598-020-80919-5
pmc: PMC7820219
doi:

Substances chimiques

Antitubercular Agents 0
DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1870

Références

Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
Salud Publica Mex. 2014 Jan-Feb;56(1):63-77
pubmed: 24912522
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
EBioMedicine. 2018 Aug;34:122-130
pubmed: 30077721
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
J Clin Microbiol. 1991 Nov;29(11):2578-86
pubmed: 1685494
APMIS. 2015 Feb;123(2):116-22
pubmed: 25257651
Nat Genet. 2013 Oct;45(10):1176-82
pubmed: 23995134
BMC Med. 2018 Oct 30;16(1):196
pubmed: 30373589
Enferm Infecc Microbiol Clin. 2016 Jul;34 Suppl 3:32-9
pubmed: 27474245
Infect Genet Evol. 2019 Aug;72:31-43
pubmed: 30593925
Genome Med. 2016 Feb 17;8(1):19
pubmed: 26883915
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Apr;36(4):233-240
pubmed: 29463429
Front Immunol. 2018 Jan 09;8:1948
pubmed: 29375571
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
Semin Immunol. 2014 Dec;26(6):431-44
pubmed: 25453224
Eur Respir J. 2021 Jan 5;57(1):
pubmed: 32732329
PLoS One. 2018 Mar 15;13(3):e0193626
pubmed: 29543819
PLoS Med. 2019 Oct 31;16(10):e1002961
pubmed: 31671150
BMC Res Notes. 2013 May 01;6:172
pubmed: 23635381
Adv Exp Med Biol. 2017;1019:135-154
pubmed: 29116633
PLoS One. 2017 Nov 1;12(11):e0186956
pubmed: 29091913
PLoS One. 2019 Jun 5;14(6):e0213046
pubmed: 31166945
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Sci Rep. 2016 Sep 12;6:33180
pubmed: 27615360
Biochemistry. 2013 Mar 19;52(11):1927-38
pubmed: 23432191
Nat Genet. 2016 Dec;48(12):1535-1543
pubmed: 27798628
J Microbiol Methods. 2016 Feb;121:33-5
pubmed: 26672684
Infect Genet Evol. 2017 Nov;55:384-391
pubmed: 27637930
Genes (Basel). 2019 Jan 16;10(1):
pubmed: 30654542
Sci Adv. 2018 Oct 17;4(10):eaat5869
pubmed: 30345355
Int J Mycobacteriol. 2017 Jan-Mar;6(1):14-20
pubmed: 28317799
J Clin Microbiol. 2014 Aug;52(8):3049-52
pubmed: 24850349
Infect Genet Evol. 2013 Mar;14:434-43
pubmed: 23333775
BMC Biol. 2020 Mar 2;18(1):24
pubmed: 32122347
J Clin Microbiol. 2016 Jul;54(7):1862-1870
pubmed: 27194683
Infect Genet Evol. 2017 Nov;55:378-383
pubmed: 27418234

Auteurs

Ana Cristina Jiménez-Ruano (AC)

Programa de Maestría en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.
Instituto de Salud Pública, Universidad Veracruzana, Av. Luis Castelazo Ayala S/N, A.P. 57, Col. Industrial Animas, 91190, Xalapa, Veracruz, México.

Carlos Francisco Madrazo-Moya (CF)

Programa de Maestría en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.
Biomedical Institute of Valencia IBV-CSIC, Valencia, Spain.

Irving Cancino-Muñoz (I)

Biomedical Institute of Valencia IBV-CSIC, Valencia, Spain.

Paulina M Mejía-Ponce (PM)

Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, Nuevo Leon, Mexico.

Cuauhtémoc Licona-Cassani (C)

Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, Nuevo Leon, Mexico.

Iñaki Comas (I)

Biomedical Institute of Valencia IBV-CSIC, Valencia, Spain.
CIBER of Epidemiology and Public Health, Madrid, Spain.

Raquel Muñiz-Salazar (R)

Laboratorio de Epidemiología y Ecología y Molecular, Escuela de Ciencias de la Salud, Universidad Autónoma de Baja California, Ensenada, Baja California, México.
Red Multidisciplinaria de Investigación en Tuberculosis, Mexico City, Mexico.

Roberto Zenteno-Cuevas (R)

Programa de Maestría en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México. robzencue@gmail.com.
Instituto de Salud Pública, Universidad Veracruzana, Av. Luis Castelazo Ayala S/N, A.P. 57, Col. Industrial Animas, 91190, Xalapa, Veracruz, México. robzencue@gmail.com.
Red Multidisciplinaria de Investigación en Tuberculosis, Mexico City, Mexico. robzencue@gmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH